Periciazine

哌氰嗪

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NamePericiazine
Drug Alias NamepericiazinumpericiazinaPericyazinePropericiazineNeuleptil +[8
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine receptors antagonists
TargetsDopamine receptors
Therapy Area/IndicationsSchizophreniaAnxiety
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsSchizophreniaAnxiety
Inactive IndicationsN/A

Other Information

ATC CodeN05AC01
Related LinksN/A